Torok KS - Search Results

1

Exploring the impact of paediatric localized scleroderma on health-related quality of life: focus groups with youth and caregivers.

Zigler CK, Ardalan K, Hernandez A, Caliendo AE, Magee KE, Terry MA, Mann CM, Torok KS. Zigler CK, et al. Among authors: torok ks. Br J Dermatol. 2020 Oct;183(4):692-701. doi: 10.1111/bjd.18879. Epub 2020 Mar 4. Br J Dermatol. 2020. PMID: 31955419

2

Pediatric scleroderma: systemic or localized forms.

Torok KS. Torok KS. Pediatr Clin North Am. 2012 Apr;59(2):381-405. doi: 10.1016/j.pcl.2012.03.011. Epub 2012 Apr 6. Pediatr Clin North Am. 2012. PMID: 22560576 Free PMC article. Review.

3

The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.

Kelsey CE, Torok KS. Kelsey CE, et al. Among authors: torok ks. J Am Acad Dermatol. 2013 Aug;69(2):214-20. doi: 10.1016/j.jaad.2013.02.007. Epub 2013 Apr 4. J Am Acad Dermatol. 2013. PMID: 23562760 Free PMC article.

4

Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.

Magee KE, Kelsey CE, Kurzinski KL, Ho J, Mlakar LR, Feghali-Bostwick CA, Torok KS. Magee KE, et al. Among authors: torok ks. Arthritis Res Ther. 2013;15(6):R188. doi: 10.1186/ar4378. Arthritis Res Ther. 2013. PMID: 24499523 Free PMC article.

5

Emotional and mental health impact of morphoea demonstrated in adults.

Torok K. Torok K. Br J Dermatol. 2015 May;172(5):1188-90. doi: 10.1111/bjd.13774. Br J Dermatol. 2015. PMID: 25963212 No abstract available.

6

Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.

Torok KS, Kurzinski K, Kelsey C, Yabes J, Magee K, Vallejo AN, Medsger T Jr, Feghali-Bostwick CA. Torok KS, et al. Semin Arthritis Rheum. 2015 Dec;45(3):284-93. doi: 10.1016/j.semarthrit.2015.06.006. Epub 2015 Jun 17. Semin Arthritis Rheum. 2015. PMID: 26254121 Free PMC article.

7

Durometry as an outcome measure in juvenile localized scleroderma.

Poff S, Li SC, Kelsey CE, Foeldvari I, Torok KS. Poff S, et al. Among authors: torok ks. Br J Dermatol. 2016 Jan;174(1):228-30. doi: 10.1111/bjd.14103. Epub 2015 Nov 18. Br J Dermatol. 2016. PMID: 26302039 Free PMC article. No abstract available.

8

Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.

Ardalan K, Zigler CK, Torok KS. Ardalan K, et al. Among authors: torok ks. Arthritis Care Res (Hoboken). 2017 Jul;69(7):1082-1087. doi: 10.1002/acr.23101. Epub 2017 Jun 7. Arthritis Care Res (Hoboken). 2017. PMID: 27696700 Free PMC article.

9

Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.

Kurzinski KL, Zigler CK, Torok KS. Kurzinski KL, et al. Among authors: torok ks. Br J Dermatol. 2019 May;180(5):1183-1189. doi: 10.1111/bjd.17312. Epub 2018 Dec 5. Br J Dermatol. 2019. PMID: 30315656 Free PMC article.

10

A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.

Zigler CK, Ardalan K, Lane S, Schollaert KL, Torok KS. Zigler CK, et al. Among authors: torok ks. Br J Dermatol. 2020 Mar;182(3):625-635. doi: 10.1111/bjd.18512. Epub 2019 Oct 23. Br J Dermatol. 2020. PMID: 31498874 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page